Live Breaking News & Updates on Agios pharmaceuticals inc

Stay informed with the latest breaking news from Agios pharmaceuticals inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Agios pharmaceuticals inc and stay connected to the pulse of your community

Form DEF 14A Amylyx Pharmaceuticals, For: Jun 06

Form DEF 14A Amylyx Pharmaceuticals, For: Jun 06
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Canada , Netherlands , Malvern , Worcestershire , United-kingdom , United-states , Cambridge , Cambridgeshire , Harvard-university , Massachusetts , Boston , California

Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024

CAMBRIDGE, Mass., April 18, 2024 -- Agios Pharmaceuticals, Inc. , a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced the company will host a...

Cambridge , Cambridgeshire , United-kingdom , Chris-taylor , Dan-budwick , Nasdaq , Agios-pharmaceuticals , Globenewswire-inc , Agios-pharmaceuticals-inc , Corporate-communications , Investor-relations ,

Director Jacqualyn Fouse Sells Shares of Agios Pharmaceuticals Inc (AGIO)

Agios Pharmaceuticals Inc (NASDAQ:AGIO), a biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of cancer and rare genetic diseases, has seen a recent insider transaction according to the latest SEC filings.

Agios-pharmaceuticals-inc , Jacqualyn-fouse , Iopharmaceutical-company , Gios-pharmaceuticals , Nsider-transaction , Nsider-transactions , Nsider-activity ,

Form PRE 14A Schrodinger, Inc. For: Apr 11

Form PRE 14A Schrodinger, Inc. For: Apr 11
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

California-institute-of-technology , California , United-states , Delaware , University-of-rochester , New-york , Bloomington , Malvern , Pennsylvania , Washington , Blackrock , University-college

Agios Publishes 2024 Environmental, Social and Governance (ESG) Report

09.04.2024 - – Report Highlights Company’s Focus on Red Blood Cell Health; Diversity, Equity & Inclusion; and Strong Corporate Governance – – Aligns with the Sustainability Accounting Standards Board (SASB) Standards for the Biotechnology and Pharmaceuticals ...

Cambridge , Cambridgeshire , United-kingdom , Chris-taylor , Brian-goff , Corporate-communications , Nasdaq , Agios-pharmaceuticals-inc , Agios-pharmaceuticals , Governance-report , Investor-relations , Agios-pharmaceuticals-chart

Agios Publishes 2024 Environmental, Social And Governance (ESG) Report

Agios Publishes 2024 Environmental, Social And Governance (ESG) Report
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , Chris-taylor , Brian-goff , Agios-pharmaceuticals-inc , Corporate-communications , Agios-pharmaceuticals , United-nations-sustainable-development-goals-un-sdgs , Pharmaceuticals-industry , Nasdaq , Company-focus-on-red-blood-cell-health

Tibsovo Market Expected to Surge with a CAGR of Approximately 5.1% by 2030

Market OverviewTibsovo (ivosidenib) is a targeted cancer therapy developed by Agios Pharmaceuticals, Inc. It is an oral, small molecule inhibitor of the isocitrate dehydrogenase 1 (IDH1) enzyme, which is mutated in various types of cancers, including acute myeloid leukemia (AML), cholangiocarcinoma, and glioma. Tibs...

United-kingdom , China , Japan , France , Canada , Australia , United-states , Germany , America , Servier-pharmaceuticals , Drug-administration

Profund Advisors LLC Has $572,000 Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)

Profund Advisors LLC reduced its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 23.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,116 shares of the biopharmaceutical company’s stock after selling 7,028 shares during the quarter. Profund […]

Canada , China , Hong-kong , Tsveta-milanova , Brian-goff , China-universal-asset-management-co , Agios-pharmaceuticals , Agios-pharmaceuticals-profile , Royal-bank , Tower-research-capital , Quarter-for-agios-pharmaceuticals , Agios-pharmaceuticals-inc

Form 10-K Nuvalent, Inc. For: Dec 31

Form 10-K Nuvalent, Inc. For: Dec 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Maine , United-states , Connecticut , Delaware , Iceland , Germany , Washington , Florida , Duke-university , North-carolina , China , New-hampshire

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Insider Theodore James Jr. Washburn Sells 504 Shares of Stock

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Insider Theodore James Jr. Washburn Sells 504 Shares of Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada , Theodore-james-jr , Nasdaq , News-ratings-for-agios-pharmaceuticals-daily , Asset-management-americas-inc , Agios-pharmaceuticals-company-profile , Goldman-sachs-group , Cantor-fitzgerald , Jpmorgan-chase-co , Agios-pharmaceuticals-trading , First-trust-advisors , Dimensional-fund-advisors